Article in Infection and immunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors at 2 institutions in 1 country.
Antonia C PerezClinical and Translational Research Center, University at Buffalo, the State University of New York, Buffalo, New York, USA.ORCID https://orcid.org/0000-0002-3726-1664
Antoinette JohnsonClinical and Translational Research Center, University at Buffalo, the State University of New York, Buffalo, New York, USA.
Ziqiang ChenDepartment of Biostatistics, University at Buffalo, the State University of New York, Buffalo, New York, USA.
Gregory E WildingDepartment of Biostatistics, University at Buffalo, the State University of New York, Buffalo, New York, USA.
Michael G MalkowskiDepartment of Structural Biology, University at Buffalo, the State University of New York, Buffalo, New York, USA.
Timothy F MurphyClinical and Translational Research Center, University at Buffalo, the State University of New York, Buffalo, New York, USA murphyt@buffalo.edu.
University at Buffalo, State University of New York · USHauptman-Woodward Medical Research Institute · US
Funding
University of Buffalo Clinical and Translational Science Institute - Supplement SchulyerUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2015 to 2024
$33.8M
Multi-Level Optimization of Membrane Proteins for CrystallographyU54GM094611 · NIGMS · HAUPTMAN-WOODWARD MEDICAL RESEARCH INST · PI DUMONT, MARK E. · 2010 to 2014
$6.3M
Exploring New Virulence Factors of the Oral Spirochete Treponema denticolaR01DE023080 · NIDCR · VIRGINIA COMMONWEALTH UNIVERSITY · PI Chunhao Chris Li · 2013 to 2026
$5.2M
Moraxella catarrhalis: virulence-based preventionR01DC012200 · NIDCD · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2012 to 2016
$1.8M
Prevention of childhood hearing loss through the development of a vaccine against Moraxella catarrhalis: an understudied cause of otitis media.F32DC015393 · NIDCD · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI PEREZ, ANTONIA COURTNEY · 2016 to 2017
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.